drugset / Trial / NCT05848128
Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to compare the efficacy and safety of 5% tavilermide ophthalmic solution to placebo for the treatment of the signs and symptoms of dry eye disease.
Timeline
- Start
- 2023-06-28
- Primary completion
- 2024-05-11
- Completion
- 2024-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tavilermide | Protein / enzyme biologic | 5 % | Topical |